Surgepays Total Revenue vs Income Before Tax Analysis
| SURG Stock | USD 3.66 0.03 0.83% |
Surgepays financial indicator trend analysis is much more than just breaking down Surgepays prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgepays is a good investment. Please check the relationship between Surgepays Total Revenue and its Income Before Tax accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
Total Revenue vs Income Before Tax
Total Revenue vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgepays Total Revenue account and Income Before Tax. At this time, the significance of the direction appears to have strong relationship.
The correlation between Surgepays' Total Revenue and Income Before Tax is 0.6. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Surgepays, assuming nothing else is changed. The correlation between historical values of Surgepays' Total Revenue and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Surgepays are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Total Revenue i.e., Surgepays' Total Revenue and Income Before Tax go up and down completely randomly.
Correlation Coefficient | 0.6 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Revenue
Total revenue comprises all receipts Surgepays generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Surgepays income statement and is an important metric when analyzing Surgepays profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from Surgepays' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The Surgepays' current Enterprise Value is estimated to increase to about 86.9 M, while Issuance Of Capital Stock is projected to decrease to 516.75.
| 2023 | 2024 (projected) | Interest Income | 1.3M | 1.1M | Reconciled Depreciation | 1.1M | 740.0K |
Surgepays fundamental ratios Correlations
Click cells to compare fundamentals
Surgepays Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgepays fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 10.0M | 7.3M | 19.5M | 34.0M | 42.1M | 44.3M | |
| Other Current Liab | 678.0K | 1.7M | 8.0M | 13.0M | 570K | 541.5K | |
| Total Current Liabilities | 7.1M | 15.3M | 10.0M | 23.5M | 12.7M | 13.3M | |
| Total Stockholder Equity | (4.7M) | (10.7M) | 3.6M | 5.0M | 28.2M | 29.7M | |
| Net Debt | 8.2M | 7.0M | 1.4M | 1.1M | (9.2M) | (8.7M) | |
| Retained Earnings | (10.9M) | (21.6M) | (35.1M) | (35.8M) | (15.2M) | (14.4M) | |
| Accounts Payable | 4.6M | 7.3M | 8.0M | 7.5M | 7.5M | 7.9M | |
| Cash | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
| Cash And Short Term Investments | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
| Common Stock Shares Outstanding | 1.9M | 2.1M | 4.4M | 12.4M | 14.9M | 15.7M | |
| Liabilities And Stockholders Equity | 10.0M | 7.3M | 19.5M | 34.0M | 42.1M | 44.3M | |
| Non Current Liabilities Total | 7.6M | 2.7M | 6.0M | 5.4M | 1.0M | 1.9M | |
| Other Current Assets | 1.4M | 172.6B | 5.6K | 111.5K | 161.9K | 153.8K | |
| Other Stockholder Equity | 6.1M | 10.7M | 38.7M | 40.8M | 43.4M | 45.6M | |
| Total Liab | 14.7M | 18.1M | 15.9M | 28.9M | 13.7M | 7.7M | |
| Total Current Assets | 3.6M | 1.3M | 13.9M | 27.6M | 33.4M | 35.0M | |
| Common Stock | 102.2K | 127.1K | 12.1K | 14.1K | 14.4K | 15.1K | |
| Non Current Assets Total | 6.4M | 6.1M | 5.6M | 6.4M | 8.8M | 9.2M | |
| Non Currrent Assets Other | 61.5K | 66.5K | 61.5K | 176.9K | (539.4K) | (512.5K) | |
| Short Long Term Debt Total | 8.5M | 7.7M | 7.7M | 8.1M | 5.4M | 3.8M | |
| Property Plant And Equipment Net | 505.4K | 605.4K | 687.1K | 1.1M | 1.3M | 1.4M | |
| Net Receivables | 3.1M | 393.1K | 3.2M | 9.2M | 9.5M | 10.0M | |
| Short Term Debt | 1.7M | 5.8M | 1.7M | 2.7M | 4.6M | 4.9M | |
| Other Assets | (4K) | 66.5K | 61.5K | 176.9K | 203.4K | 213.5K | |
| Long Term Debt | 6.6M | 1.7M | 5.5M | 5.0M | 460.5K | 437.5K | |
| Inventory | (172.6B) | 178.3K | 4.4M | 11.2M | 9.0M | 9.5M | |
| Intangible Assets | 4.8M | 4.1M | 3.4M | 3.2M | 2.7M | 2.0M | |
| Property Plant Equipment | 31.0K | 505.4K | 236.8K | 687.1K | 790.2K | 829.7K | |
| Net Tangible Assets | (2.9M) | (10.3M) | (15.7M) | (749.2K) | (674.3K) | (708.0K) | |
| Short Long Term Debt | 2.1M | 5.9M | 1.7M | 2.7M | 4.6M | 2.5M | |
| Other Liab | 883.6K | 600.5K | 869.9K | 852.0K | 979.8K | 808.9K | |
| Net Invested Capital | 4.0M | (3.1M) | 10.7M | 12.7M | 33.3M | 35.0M | |
| Net Working Capital | (3.5M) | (14.1M) | 3.9M | 4.1M | 20.7M | 21.7M | |
| Capital Stock | 115.9K | 140.9K | 12.3K | 14.1K | 14.4K | 13.7K |
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share 1.14 | Revenue Per Share 8.832 | Quarterly Revenue Growth (0.1) | Return On Assets 0.1806 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.